Sort   by:  
 Page size 
Human prostate carcinoma cell line PC3 was treated with 10mg/ml or 100mg/ml of Abacavir. Gene expression was analyzed on total RNA extracted 48h after treatement. For each condition, 5 indipendent biological replicates were performed
ORGANISM(S): Homo sapiens 
Objective: to compare changes in gene expression by microarray from subcutaneous adipose tissue from HIV treatment naïve patients treated with efavirenz based regimens containing abacavir (ABC), tenofavir (TDF) or zidovidine (AZT). There were significant divergence between ABC and the other two grou...
ORGANISM(S): Homo sapiens 
Characterisation of the kinetics of abacavir-induced perturbation of the immunopeptidome of the Major Histocompatibility Complex (MHC) class I molecule HLA-B*57:01.
ORGANISM(S): Homo sapiens (Human) 
2021-05-11 | PXD024331 | Pride
Characterisation of peptide ligands of the Major histocompatibility class (MHC) I allele, HLA-B*57:01, expressed in the C1R (Class I reduced) B-lymphoblastoid cell line, after exposure to the anti-retroviral abacavir or abacavir analogues.
ORGANISM(S): Homo sapiens (Human) 
2019-10-03 | PXD015398 | Pride
Analysis of human leukocyte antigen (HLA) allotype-specific response in abacavir-exposed keratinocyte
Abacavir, a nucleoside reverse-transcriptase inhibitor used for the treatment of human immunodeficiency virus (HIV) infection, develops hypersensitivity in patients carrying HLA-B*57:01 allele through drug antigen presentation. We found that abacavir exposure induced HLA allotype-specific innate imm...
ORGANISM(S): Mus musculus 
2018-03-01 | GSE110394 | GEO
Abacavir-induced hypersensitivity project
Genomics
Microbial diversity of abacavir degrading microbial community
Sort   by:  
 Page size